anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
By 31st December 2019, 27 subjects with pneumonia of unknown aetiology were registered in Wuhan City, China. 7th of January the disease causative agent was identified and turned to be severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The WHO named the disease - coronavirus disease (COVID-19). On March 11, 2020, the World Health Organization (WHO) announced that COVID-19 should be characterized as a pandemic. At great economic cost, many countries have adopted unprecedented measures to curb the spread of the virus, such as large-scale use of isolation and quarantine, closing borders, imposing limits on public gatherings, and implementing nationwide lockdowns.

The most common symptoms of COVID-19 are fever, tiredness, and dry cough. Some patients may exhibit nasal congestion, runny nose, sore throat or diarrhea. These symptoms are usually mild and begin gradually. About 40% of the symptomatic patients recover from the disease without needing special treatment. Around 1 out of every 6 people infected with SARS-CoV-2 becomes seriously ill and develops difficulty breathing. Older people, and those with underlying medical problems like high chronic cardiovascular and respiratory disease or diabetes, are more likely to develop serious illness.

Monitoring patients with resolution of COVID-19 pneumonia is important in terms of when they should be released from isolation and discharged and to what extent this result is correlating with the clinical severity. If patients are still shedding viable coronavirus, they are likely to infect others. Therefore, quarantine for up to one month may be advisable. The optimal method for test of cure most likely will be two consecutive negative real-time RT-PCR tests. Furthermore, people who have cleared SARS-CoV-2 could have developed specific antibodies against the infectious agent in their blood plasma as a result of humoral immune response. This plasma is rich with specific antibodies and is called convalescent plasma (CP) or convalescent serum (CS). CP could treat and eradicate SARS-CoV-2 in infected individuals and could be used as therapy. This therapy concept was centuries old and was previously attempted during several outbreaks. Currently, there are few reports from China and South Korea showing that patients who received CP transfusion together with antiviral drugs and corticosteroids have recovered from the disease.

It is the aim of the COVeR study to enroll 400 patients with COVID-19 from nursing homes of the german state Mecklenburg-Vorpommern. Each patient will enter a follow-up phase of 6 months during which buccal swaps will be collected for judging the viral load, and blood samples for investigation of their immune response and identifying predictive biomarkers.
PURPOSE: To obtain the subject compound useful for treating ovarian, mammary, pulmonary cancers, etc., with good productivity by culturing a tissue, a cell, etc., of a plant capable of producing a taxane type diterpene using a gas containing oxygen and further gaseous carbon dioxide at a specific concentration. CONSTITUTION: A tissue (e.g. a stem) of a plant (e.g. Taxus breviflolia) capable of producing a taxane type diterpene (e.g. taxol) is bedded on a solid culture medium containing gellan gum, etc., to carry out the stationary culture in the dark at 25 deg.C. A callus is produced and the resultant cultured cell is transferred to a liquid culture medium and cultured at 25 deg.C in the dark for 21 days under stirring while aerating a gas containing oxygen and further gaseous carbon dioxide at >=0.04% concentration. The cell is then recovered by filtration and the recovered cell is freeze-dried to carry out the extraction with methanol, etc. The solvent is distilled away from the extract solution and the purification is performed according to the high-performance liquid chromatography. Thereby, the objective taxane type diterpene useful as a therapeutic agent for ovarian, mammary, pulmonary cancers, etc., is obtained with improved productivity.
Because simvastatin tablets do not undergo significant renal excretion, modification of dosage should not be necessary in patients with mild to moderate renal impairment. However, caution should be exercised when simvastatin tablets are administered to patients with severe renal impairment; such patients should be started at 5 mg/day and be closely monitored [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)].  
_________________________  
  
1National Cholesterol Education Program (NCEP): Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 89(3):495-501. 1992.
Observation for triple negative breast cancer (TNBC): No adjuvant chemotherapy. Patients may complete checkpoint inhibitor from neoadjuvant setting. human epidermal growth factor receptor 2 (HER2) positive breast cancer: complete twelve months of anti-HER2 therapy, which was initiated in neoadjuvant setting), participants in the observation arm, will be monitored for Circulating tumor DNA (ct-DNA) re-emergence and systemic therapy can be added at the time of ctDNA re-emergence.
A composition is prepared by extracting phytochemicals from plant matter. This composition is enriched preferably in isoflavones, lignans. saponins. catechins and phenolic acids. Soy is the preferred source of these chemicals: however other plants may also be used, such as red clover, kudzu, flax, and cocoa. The composition is a dietary supplement for treatment of various cancers, pre- and post-menstrual syndromes, and various other disorders.
PROBLEM TO BE SOLVED: To obtain a composition containing a reducing thio compound and an unsaponified component of a vegetable oil and giving excellent wave effect, combing smoothness and luster to the hair without damaging the hair even by repeating the treatment. SOLUTION: This composition contains a reducing thio compound (e.g. ammonium thioglycolate) and 0.01-2.5wt.% of an unsaponified component of a vegetable oil containing >=20wt.% of phytosterol. The reducing thio compound may be used singly or as a combination of two or more thio compounds and the amount of the reducing agent including the reducing thio compound is preferably 2.5-15wt.% in terms of free thioglycolic acid. The content of the unsaponified component in the vegetable oil including triglyceride and other components is 30-60wt.%. The vegetable oil is e.g. avocado oil. The composition is properly compounded further with an alkalizing agent, a surfactant, a polymer, etc., and used in the form of an (aqueous) solution, emulsion, cream, foamable agent, etc.
Knee osteoarthritis (OA) is a prevalent musculoskeletal condition that impacts the quality of life. Despite various treatment options, managing knee OA is still a challenge for healthcare professionals. However, there is growing interest in exploring the innovative interventions to decrease symptoms and improve functional outcome in patients with knee OA.The project will be a Randomized control trial conducted to check the effect of Virtual Reality and Kinetic chain exercises in patients with knee osteoarthritis.so that we can have best treatment option. Duration of this study will be of 8 weeks , convenient sampling will be done, subjects following eligibility criteria from IIMCT Pakistan Railway general Hospital will be randomly allocated in two groups, baseline assessment will be done, Group A will be given Xbox kinetic training and Group B will be given Kinetic chain exercises . Outcome measures if this research will be pain , Range if Motion , function and disability. Post intervention assessment will be done via NPRS , WOMAC , KOOS_PS and goniometric measurements of Knee ranges .Data was analyzed by using SPSS software. There is lack of research comparing the effectiveness of Virtual Reality Xbox Kinect and kinetic chain exercises in patients with knee osteoarthritis. There are studies that have explored the effectiveness of these interventions separately. In past, few researches support the fact that virtual reality rehabilitation is more effective than conventional physical therapy and few researches are in support of kinetic chain exercises being more effective for knee osteoarthritis. However there is no study that has compared these both interventions. Therefore there is a need for further research to compare both of these interventions which in future will provide optimal, more personalized and effective rehabilitation strategy for individuals with knee osteoarthritis
Considering the influence of dietary factors on inflammatory markers that may affect the disease course in patients with ulcerative colitis (UC), this study aimed to assess the association between dietary inflammatory index (DII) score and disease activity in patients with ulcerative colitis. This cross-sectional study included 158 patients with UC. The Mayo Clinic score was used to determine the disease severity. A food frequency questionnaire was applied to gather the dietary information, then the Shivappa et al. method was used for the calculation of DII. An association between disease severity (dependent factor) and DII score quartiles (independent factors) was conducted by a logistic regression adjusted to different covariates. In this study, 53.8% of participants were in remission or had mild disease activity. The mean DII score was - 0.24 ± 0.66. The mean DII score was significantly lower in patients with remission (-0.34 ± 0.71) compared with patients who were in the active phase (-0.1 ± 0.57) of UC (P = 0.02). The results of the logistic regression analysis showed that after adjusting for confounding factors, the odds of severe disease were 3.33 times higher among patients who had a more pro-inflammatory diet compared with patients who had an anti-inflammatory diet [OR: 3.33 (95%CI: 1.13, 9.76), p = 0.02]. In conclusion, there was a significant association between higher intake of a pro-inflammatory diet and UC severity. So, from a clinical point of view, there is a need to apply an anti-inflammatory diet to decrease disease severity in patients with ulcerative colitis.
Plyometric training has been used in a variety of sports to improve power. There is minimal research however regarding its use among hockey players and even less research exploring water based training. International field hockey competitions are played on wet turf and it is felt that water training may be beneficial to these players. The study will explore whether water based plyometrics will prove to have additional benefits compared to land based plyometrics for the Jamaican hockey athletes. The members of the Jamaica hockey clubs will be recruited to participate in this study. Recruitment will be done by the principal investigator Dr. Roopchand-Martin. A total of 34 persons will be recruited and they will be randomly allocated to aquatic or land based training. All training programmes will be conducted at the section of physical therapy and training will be done two times per week for 6 weeks. Baseline assessments will be done independent evaluators for lower limb power using the Standing Broad Jump and Vertical Jump Test, anaerobic power using the Running Anaerobic Sprint test, agility using the Illinois agility and T tests, flexibility using the Sit and Reach Test and performance during game play on wet artificial turf in relation to time-motion analysis for total distance covered, and total time, average and maximum pace, average and maximum heart rate, time in heart zones 1-5, and changes in rate of perceived exertion.
Balance; within the limits of the stability of the center of gravity can be controlled on the surface. Balance can be affected due to muscle weakness after stroke, abnormal muscle tone, loss of deep sensation and disturbances in vestibular mechanisms. Among all sensorimotor results of stroke, it is stated that the balance of postural control has the greatest effect on daily living activities and gait. Accurate assessment of balance in stroke patients is important in identifying appropriate aids for mobility, choosing an effective treatment program, determining safe and unsafe activities, and setting rehabilitation goals. The most common risk factor for falls is one of the most important risk factors for stroke. Therefore, reliable and accurate measurement of dynamic gait balance is an important issue in stroke patients.The 3 m walk-back test is used to assess neuromuscular control, proprioception, protective reflexes, fall risk, and balance. In a study of healthy elderly adults, a 3-m walk-back test showed better diagnostic accuracy compared to the most commonly used measurement methods for falls in the past year. Reliability is extremely important, especially for research and clinical applications. In order to assess the risk of falling, measurement methods need to be reliable and change accurately over time. 3 m walk back test was found to be reliable in healthy elderly individuals. However, there are no studies investigating the validity and reliability of this test in stroke patients.
PURPOSE: To obtain nonphosphate peptide by hydrolyzing a casein containing univalent cationic salt of phosphorus casein or its derlv. with a specified protein decomposing enzyme and then subjecting the hydrolysate to ultrafiltration. CONSTITUTION: A univalent cationic salt of phosphorus casein or its deriv. is hydrolyzed by using one or more kinds of protein decomposing enzymes which can reproduce digestion of protein in a human body. The obtd. hydrolysate is filtered through one or more ultrafiltration membranes. Then one or more kinds of bivalent cationic salts which can form aggregates of phosphopeptide are added to the filtrate to produce phosphopeptide aggregates and nonphosphate peptide. Then the liquid is subjected to ultrafiltration to obtain a nonphosphate peptide containing >=12% total aromatic amino acid, <=4% serine, <10% isolated amino acid.
The escape room game will include a patient scenario of four female patients who are victims of violence and apply to different clinics. Necessary equipment and materials will be provided and stations will be established where four female patients who are victims of violence will be evaluated. In order for them to solve puzzles and puzzles related to the subject at the stations; Colorful puzzle set, lettered chest lock, ballot box, colorful stickers, digital countdown clock, and materials to be used by students will be provided by the researchers. In the game, each student will contact the patient at only one station and evaluate signs and symptoms of violence. The group, which completes the tasks and activities and collects the puzzle pieces that will lead to the code of the lock, will complete the puzzle and enter the number codes on it into the key of the locked box on the table (4 numerical codes received), open the box and get the message 'you can escape'.
FIELD: medicine, biotechnology, immunology, proteins. SUBSTANCE: invention relates to soluble polypeptide fractions of protein LAG-3, method of their preparing, therapeutical composition and antibodies. Invention involves soluble polypeptide fractions of membrane protein LAG-3 that can be used as immunosuppressants, method of their preparing and antibodies that are able to prevent specific fixation of protein LAG-3 on CMH molecules (the main complex of histocompatibility) of class II and can be used as immunostimulators. The claimed peptides show ability to bind with CMH molecules of class II and immunosuppressing effect in combination with unexpected immunostimulating effect of anti-CD4-antibodies. EFFECT: improved method of preparing, valuable immunological properties of polypeptide fraction. 14 cl, 15 dwg, 5 tbl
We present a 58-year-old female patient who underwent resection of a leiomyosarcoma arising from the right ovarian vein. She was referred to our hospital because of lower abdominal pain that had been present for 1 month prior to the visit. Ultrasound examination revealed a well-defined, smooth, lobulated, highly vascular mass(57 mm)adjacent to the distal portion of the duodenum. Contrast-enhanced computed tomography revealed the contrast enhancement mass (60 mm)located surround the right ovarian vein. In abdominal magnetic resonance image examination, the mass exhibited isointense signal on T1-weighted images, high signal on T2-weighted images, and restricted diffusion on diffusion- weighted images. We suspected primary leiomyosarcoma of the ovarian vein and proceeded with surgical intervention. On intraoperative findings, the mass was in contact with the duodenum and the inferior vena cava but dissection was easily achieved. We excised the mass together with the right ovarian vein. Pathological findings showed the mass was composed of proliferating spindle-shaped cells arranged in bundles. Some areas showed polygonal nuclear atypia and abnormal mitotic figures. Additional immunostaining showed positive for α-SMA, caldesmon, calponin, and negative for desmin, CD34, CKA1/AE3, S100. Based on the intraoperative findings, we diagnosed it as leiomyosarcoma arising of the right ovarian vein.
Module Part B4: Patients with second or third line triple negative breast cancer with no known BRCA mutations. This expansion will be enriched for patients with disease harbouring a HRR-related gene mutation (HRRm) will receive ceralasertib with olaparib, at dose, frequency and schedule recommended from Module 2 Part A2.
The plasma trough concentration of sirolimus is maintained within the range of 10-15 ng/ml by adjusting sirolimus dose, for 6 months. Then, The plasma trough concentration of sirolimus is maintained within the range of 5-8 ng/ml by adjusting sirolimus dose, for 6 months.
This study was planned as a single blind randomized controlled type in order to examine the effect of yoga on sexual function in primipara pregnant women. The data of the research will be collected through the "Data Collection Form, Female Sexual Function Scale (FSFI)" and The Body Exposure During Sexual Activities Questionnaire (BESAQ), which are created by the researchers by scanning the literature. Research Volunteers who apply to SBU Haseki Training and Research Hospital Pregnancy Outpatient Clinic and meet the sample selection criteria will constitute the sample of the study. In order to determine the minimum sample size required for this study, the power analysis 80% power and α = 0.50 were calculated to include a total of 138 women with a minimum 69 sample size in each group. The intervention and control ratio is 1. However, considering the probability of loss, 150 pregnant women will be randomized. The data will be interviewed online with pregnant women and online yoga training will be held for the intervention group, and the data will be uploaded to the ISM SPSS 22.0 (Statistical Package for the Social Sciences) statistics program; Parametric (Anova and T test) and nonparametric (Mann-Whitney U Test, Kruskal Wallis, Chi Square) statistical methods will be used.
In this single-arm study, patients will receive 7.4 GBq of 177Lu-PSMA-I\&T on Day 1 of every 6 week Cycle. Radium-223 will be administered concurrently every 6 weeks. The dose of Radium-223 will vary in dose-escalation. Up to 6 Cycles will be given.
OBJECTIVES: This study aimed to assess the incidence of late-onset sepsis (LOS), associated risk factors, and short-term prognosis in very low birth weight (VLBW) infants in a 10-year period.
STUDY DESIGN: A cohort study was conducted with 752 VLBW preterm infants-23 to 33 gestational weeks and 400 to 1,500 g birth weight-admitted to a neonatal intensive care unit from 2008 to 2017 and who survived over 72 hours. LOS was defined as clinical and laboratory signs of infection, whether or not confirmed by blood culture. VLBW infants were divided into groups and compared: no LOS versus proven LOS versus clinical LOS. Study variables included maternal, birth, and neonatal data, morbidities, procedures, etiological agents, and outcome-death, bronchopulmonary dysplasia (BPD), severe intraventricular hemorrhage, and retinopathy of prematurity (ROP). Analysis of variance with multiple Tukey's or Wald's comparison with gamma distribution, and stepwise multiple logistic regression model, adjusted for year, and gestational age, were used for statistical analysis.
RESULTS: LOS incidence was 39% (proven LOS: 29%; clinical LOS: 10%). Septic VLBW infants showed higher mortality (proven LOS: 23.2%; clinical LOS: 41.9%) compared with no LOS (8.9%). Coagulase-negative staphylococci (56%), Gram-negative (26%), and fungi (8%) were the most frequent etiological agents. In comparing the groups, septic VLBW infants had lower gestational age and birth weight, presented more morbidities, and underwent more invasive procedures. The risk factors for proven and clinical LOS were days of mechanical ventilation and parenteral nutrition. LOS was associated with increased risk of death, BPD, and ROP.
CONCLUSION: LOS showed high incidence and mortality, often caused by Gram-positive bacteria. Care interventions were the main risk factors associated. LOS had a major negative impact on short-term prognosis in VLBW infants. LOS reduction strategies are necessary and urgent.
KEY POINTS: · LOS is associated with clinically significant neonatal morbidities and death in VLBW premature infants.. · There is association between LOS and duration of intensive care interventions.. · Quality improvement initiatives can be a pathway for LOS reduction..
Patients will be divided, 5 per group, into Groups I, II, III and IV. Groups I and II will include patients who have decided not to take anti-retro viral drugs. Groups III and IV will include patients receiving the same types of antiretroviral drugs. Patients in groups I and III will receive thalidomide while patients in group II and IV will receive placebo. The placebo capsules will be the same color as the thalidomide capsules and will contain glucose powder. Patients will ingest one capsule of thalidomide at 9 PM daily on days 0, 1, 2, 3, 4, 5 and 6.
Randomly assigned patients attending cancer clinics at Washington or Georgia sites during February 2013 to August 2013 will be presented with or mailed a survey about cancer communication approximately 2 weeks later and a follow-up survey approximately 3 months later. Additionally, this group will also receive a follow-up phone call approximately 4 weeks after baseline survey.
Participants are required to complete one colonoscopy and during the procedure, 150ml of saline is infused into the terminal ileum on day 0. Subsequently, participants don't need any treatment. The participants will receive their first colonoscopy follow-up 6 to 12 months after enrollment.
The dose of ASN001 will be based on the assigned study group. The initial dose level of ASN001 will be 50 mg daily. After a safety review, the dose may be escalated for the next group of subjects. Additional dose levels are 100 mg, 200 mg, 300 mg, and 400 mg.
PROBLEM TO BE SOLVED: To obtain a skin lotion excellent in preservation stability, especially stability at a low temperature. SOLUTION: This skin lotion contains a lysophospholipid and a fatty acid ester of sucrose, and >=80 wt.% of the fatty acid ester of the sucrose is a monoester. The fatty acid ester of the sucrose is the one obtained by forming an ester bond between one or more hydroxy groups in the sucrose and a saturated or unsaturated fatty acid, and the constituent fatty acid is the one having about 10-24 carbons, concretely, e.g. lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid and behenic acid. The lysophospholipid is any one of monoacyl type phospholipids, e.g. lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylinositol, lysophosphatidic acid and lysophosphatidylserine, and a mixture thereof can be also used.